Nos publications
Estimating in vivo drug release from a new theophylline Compritol® 888 ATO matrix formulation using appropriate biorelevant test methods
CRS Annual Meeting – Chicago (USA) - jui 2014
A tunable Caco-2/HT29-MTX co-culture model mimicking variable permeabilities of the human intestine obtained by an original seeding procedure
European Journal of Pharmaceutics and Biopharmaceutics, Volume 87, Issue 2, Pages 290-298 https://doi.org/10.1016/j.ejpb.2014.03.017 - jui 2014
Colour coating of Compritol® 888 ATO matrix tablets: a feasability study
AAPS Annual Meeting and Exposition – San Diego (USA) - 2014
Establishment of a binary phase diagrams database for the development of self-emulsifying lipid-based formulations
AAPS Annual Meeting and Exposition – San Diego (USA) - 2014
Formulation of a self-emulsifying lipid formulation of curcumin
AAPS Annual Meeting & Exposition – San Diego (USA) - 2014
Rectal route in the 21st century to treat children.
Advanced Drug Delivery Reviews, Volume 73, Pages 34-49 https://doi.org/10.1016/j.addr.2014.05.01 - jui 2014
Polyoxylglycerides and glycerides: Effects of manufacturing parameters on API stability, excipient functionality and processing
International Journal of Pharmaceutics, Volume 466, Issues 1–2, Pages 109-121 - mai 2014
Smart strategies for sustained release matrix tablets: Compritol® 888 ATO
OutsourcingPharma - mai 2014
This white paper gives an overview of how Compritol® 888 ATO provides clinically relevant sustained drug release profiles along with biopharmaceutical, formulation and manufacturing advantages.
Measuring solubility performance of skin penetration enhancers for three anti-inflammatory drugs
PBP World Meeting – Vienna (Austria) - mar 2014